• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

照射野大小及其他放疗参数对咽喉癌急性毒性的影响。

The influence of field size and other radiotherapy parameters on acute toxicity in pharyngolaryngeal cancers.

作者信息

Miralbell R, Allal A S, Mermillod B, Pastoors B

机构信息

Radiation Oncology Department, University Hospital of Geneva, Switzerland.

出版信息

Strahlenther Onkol. 1999 Feb;175(2):74-7. doi: 10.1007/BF02753846.

DOI:10.1007/BF02753846
PMID:10065142
Abstract

BACKGROUND

Accelerated radiotherapy and/or chemo-radiotherapy of the head and neck region decrease the tolerance of acute responding tissues. Tissue tolerance is also field size dependent.

PATIENTS AND METHOD

An attempt to retrospectively quantify the risk of acute toxicity (peak scores) with field size was undertaken in 286 patients irradiated for unresected head and neck tumors with or without chemotherapy, and with or without accelerated radiotherapy between 1979 and 1990. A Grade-3 to -4 acute toxicity score (RTOG) and > 5% weight loss were chosen as endpoints.

RESULTS

For Grade-3 to -4 toxicity, the risk increased from 0.06 for 5 x 5 cm2 to 0.68 for 17 x 17 cm2 fields and conventional radiotherapy, and from 0.33 for 5 x 5 cm2 to 0.94 for 17 x 17 cm2 and multiple daily fractionation. For > 5% weight loss, the risk ranged from 0.07 for 5 x 5 cm2 to 0.94 for 17 x 17 cm2 fields.

CONCLUSIONS

The size of the cervical fields receiving the first 50 Gy was an indicator for severe acute toxicity and weight loss. Taking these data into account may help to improve preventive and treatment measures.

摘要

背景

头颈部区域的加速放疗和/或放化疗会降低急性反应组织的耐受性。组织耐受性也与照射野大小有关。

患者与方法

对1979年至1990年间接受未切除头颈部肿瘤放疗的286例患者进行回顾性研究,试图量化照射野大小与急性毒性(峰值评分)风险之间的关系,这些患者接受或未接受化疗,以及接受或未接受加速放疗。选择3至4级急性毒性评分(RTOG)和体重减轻>5%作为终点指标。

结果

对于3至4级毒性,在常规放疗中,照射野面积从5×5平方厘米时的0.06增加到17×17平方厘米时的0.68;在每日多次分割放疗中,照射野面积从5×5平方厘米时的0.33增加到17×17平方厘米时的0.94。对于体重减轻>5%,照射野面积从5×5平方厘米时的0.07到17×17平方厘米时的0.94不等。

结论

接受前50 Gy照射的颈部照射野大小是严重急性毒性和体重减轻的一个指标。考虑这些数据可能有助于改进预防和治疗措施。

相似文献

1
The influence of field size and other radiotherapy parameters on acute toxicity in pharyngolaryngeal cancers.照射野大小及其他放疗参数对咽喉癌急性毒性的影响。
Strahlenther Onkol. 1999 Feb;175(2):74-7. doi: 10.1007/BF02753846.
2
Accelerated hyperfractionated radiotherapy and concurrent protracted venous infusion chemotherapy in locally advanced head and neck cancer.局部晚期头颈癌的加速超分割放疗与同步持续静脉输注化疗
Am J Clin Oncol. 2002 Oct;25(5):431-7. doi: 10.1097/00000421-200210000-00001.
3
[Induction chemotherapy and laryngeal preservation in pharyngolaryngeal carcinomas. Study of a 124 serie's patients and patient's follow up with laryngeal preservation].
Rev Laryngol Otol Rhinol (Bord). 2004;125(2):81-8.
4
[Results of surgical treatment of cancers of the hypopharynx (253 cases)].
Acta Otorhinolaryngol Belg. 1973;27(8):1029-40.
5
[Results and indications of telecobalt therapy of cancer of the larger air-oral digestive passages (author's transl)].[口腔与消化道较大部位癌症的远距钴治疗结果与适应症(作者译)]
Radiobiol Radiother (Berl). 1978;19(1):33-44.
6
Radiation therapy in the management of lymph node metastases from head and neck cancers.放射治疗在头颈部癌淋巴结转移管理中的应用
Am J Roentgenol Radium Ther Nucl Med. 1972 Jan;114(1):76-82.
7
[High-energy radiotherapy in the treatment of epitheliomas of the hypopharynx].
Acta Otorhinolaryngol Belg. 1973;27(8):1017-24.
8
Tumor sterilization following high-dose pre-operative irradiation for advanced cancer of the larynx or pyriform sinus.
Radiology. 1979 Jul;132(1):171-4. doi: 10.1148/132.1.171.
9
Neoadjuvant chemotherapy with carboplatin/5-fluorouracil in head and neck cancer.
Oncology. 1993 Nov;50 Suppl 2:23-7. doi: 10.1159/000227257.
10
Smart (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy.智能(同步调制加速放射治疗)推量:一种用于头颈部癌调强放射治疗的新加速分割方案。
Int J Radiat Oncol Biol Phys. 1999 Aug 1;45(1):21-32. doi: 10.1016/s0360-3016(99)00101-7.

引用本文的文献

1
Clinical effects of flurbiprofen tooth patch on radiation-induced oral mucositis. A pilot study.氟比洛芬牙贴对放射性口腔黏膜炎的临床疗效:一项初步研究。
Support Care Cancer. 2005 Jan;13(1):42-8. doi: 10.1007/s00520-004-0674-6. Epub 2004 Sep 9.
2
Oral mucositis and selective elimination of oral flora in head and neck cancer patients receiving radiotherapy: a double-blind randomised clinical trial.头颈部癌症放疗患者的口腔黏膜炎及口腔菌群的选择性清除:一项双盲随机临床试验
Br J Cancer. 2003 Apr 7;88(7):1012-6. doi: 10.1038/sj.bjc.6600824.

本文引用的文献

1
Combined concomitant boost radiotherapy and chemotherapy in stage III-IV head and neck carcinomas: a comparison of toxicity and treatment results with those observed after radiotherapy alone.III-IV期头颈癌同步加量放疗与化疗联合应用:毒性及治疗结果与单纯放疗的比较
Ann Oncol. 1997 Jul;8(7):681-4. doi: 10.1023/a:1008260720076.
2
Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial.与传统分割放疗(CF)相比,加速分割放疗(AF)可改善晚期头颈癌放疗的局部区域控制:欧洲癌症研究与治疗组织(EORTC)22851随机试验的结果
Radiother Oncol. 1997 Aug;44(2):111-21. doi: 10.1016/s0167-8140(97)00079-0.
3
Early and long-term results of an original accelerated radiation therapy schedule in head and neck carcinoma.
Acta Oncol. 1997;36(3):267-71. doi: 10.3109/02841869709001261.
4
A randomised trial of accelerated versus conventional radiotherapy in head and neck cancer.头颈部癌加速放疗与传统放疗的随机试验。
Radiother Oncol. 1997 Apr;43(1):39-46. doi: 10.1016/s0167-8140(97)01944-0.
5
Rapidly alternating chemotherapy and hyperfractionated radiotherapy in the management of locally advanced head and neck carcinoma: four-year results of a phase I/II study.局部晚期头颈癌治疗中快速交替化疗与超分割放疗:一项I/II期研究的四年结果
J Clin Oncol. 1994 Sep;12(9):1876-85. doi: 10.1200/JCO.1994.12.9.1876.
6
Implications of the quadratic cell survival curve and human skin radiation "tolerance doses" on fractionation and superfractionation dose selection.
Int J Radiat Oncol Biol Phys. 1982 Jul;8(7):1135-42. doi: 10.1016/0360-3016(82)90061-x.
7
Dose fractionation, dose rate and iso-effect relationships for normal tissue responses.正常组织反应的剂量分割、剂量率和等效效应关系。
Int J Radiat Oncol Biol Phys. 1982 Nov;8(11):1981-97. doi: 10.1016/0360-3016(82)90459-x.
8
Twice-a-day radiation therapy for cancer of the head and neck.
Cancer. 1985 May 1;55(9 Suppl):2100-4. doi: 10.1002/1097-0142(19850501)55:9+<2100::aid-cncr2820551411>3.0.co;2-a.
9
A unified approach to dose-effect relationships in radiotherapy. I: Modified TDF and linear quadratic equations.
Int J Radiat Oncol Biol Phys. 1988 Mar;14(3):549-56. doi: 10.1016/0360-3016(88)90273-8.
10
Time-dependent tumour repopulation factors in linear-quadratic equations--implications for treatment strategies.线性二次方程中与时间相关的肿瘤再增殖因子——对治疗策略的影响
Radiother Oncol. 1989 Aug;15(4):371-81. doi: 10.1016/0167-8140(89)90084-4.